Detalhe da pesquisa
1.
Decreased soluble IFN-ß receptor (sIFNAR2) in multiple sclerosis patients: A potential serum diagnostic biomarker.
Mult Scler
; 23(7): 937-945, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-27613121
2.
Development and validation of an ELISA for quantification of soluble IFN-ß receptor: assessment in multiple sclerosis.
Bioanalysis
; 7(22): 2869-80, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26571364
3.
Killer-cell immunoglobulin-like receptor expression on lymphocyte subsets in multiple sclerosis patients treated with interferon-ß: evaluation as biomarkers for clinical response.
CNS Drugs
; 28(6): 559-70, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24599774
4.
Candidate gene study of TRAIL and TRAIL receptors: association with response to interferon beta therapy in multiple sclerosis patients.
PLoS One
; 8(4): e62540, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-23658636